{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:20:46Z","timestamp":1755224446839,"version":"3.43.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhangzhou natural science foundation projects","award":["ZZ2024J32"],"award-info":[{"award-number":["ZZ2024J32"]}]},{"name":"Zhangzhou Health Vocational College scientific research project","award":["ZWYXJ202403"],"award-info":[{"award-number":["ZWYXJ202403"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,11]]},"abstract":"<jats:p>With the aging population, the prevalence of sarcopenia and primary osteoporosis is increasing. However, the underlying mechanisms linking these 2 diseases remain unclear. The study aims to identify potential genes and pharmacological targets associated with both diseases through bioinformatics analysis. Datasets GSE35958 (primary osteoporosis) and GSE1428 (sarcopenia) were sourced from the gene expression omnibus database. Differentially expressed genes common to both conditions were identified, and functional roles were elucidated using gene ontology and Reactome pathway analyses. Protein\u2013protein interaction networks and hub genes were analyzed using Cytoscape with the molecular complex detection plugin. Key gene expression profiles were validated by quantitative real-time PCR, and potential gene\u2013drug interactions were explored using the drug\u2013gene interaction database. The identified pharmacological agents contributed to the formulation of therapeutic strategies for both diseases. Our study identified 80 commonly expressed genes through the gene expression omnibus database. Gene ontology enrichment analysis was employed to categorize these genes into biological processes, cellular components, and molecular functions. Additionally, 6 Reactome pathways were identified (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05), leading to the characterization of 65 genes. The study conducted a protein\u2013protein interaction analysis and employed molecular complex detection to evaluate a set of 65 genes, ultimately identifying 5 central genes. In this investigation, cancellous bone and muscle tissues from elderly individuals with osteoporosis and sarcopenia were subjected to quantitative real-time PCR validation. The analysis revealed that 5 genes were down-regulated in muscle tissue, whereas AXL, ERBB2, and GAB1 were up-regulated in bone tissue. Subsequently, these 5 genes were analyzed for drug\u2013gene interactions, resulting in the identification of 13 Food and Drug Administration-approved drugs with potential therapeutic applications for osteoporosis and sarcopenia. The aforementioned 5 genes (AXL, GAB1, ERBB2, NRP2, and ESR1) along with 13 pharmacological agents represent promising candidates for enhancing the treatment of osteoporosis and sarcopenia. Investigations into gene\u2013drug correlations and analyses of potential pharmacotherapies offer novel insights for drug repurposing and the exploration of therapeutic pathways.<\/jats:p>","DOI":"10.1097\/md.0000000000042975","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T18:01:49Z","timestamp":1752516109000},"page":"e42975","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Biomedical identify the drugs between primary osteoporosis and sarcopenia"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3416-7637","authenticated-orcid":false,"given":"Zhangxin","family":"Chen","sequence":"first","affiliation":[{"name":"Zhangzhou Health Vocational College, Zhangzhou, China"},{"name":"Department of Spine Surgery, Renmin Hospital of Wuhan University, Wuhan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxing","family":"Lin","sequence":"additional","affiliation":[{"name":"Zhangzhou Health Vocational College, Zhangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengjin","family":"Wang","sequence":"additional","affiliation":[{"name":"Zhangzhou Health Vocational College, Zhangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250812","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2468-2667(23)00123-8","article-title":"The burden and trend of diseases and their risk factors in Australia, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"8","year":"2023","journal-title":"Lancet Public Health"},{"key":"R2-20250812","doi-asserted-by":"crossref","first-page":"101782","DOI":"10.1016\/j.beem.2023.101782","article-title":"Bone health and menopause: osteoporosis prevention and treatment.","volume":"38","author":"de Villiers","year":"2024","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R3-20250812","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00125-023-06054-8","article-title":"Hyperglycaemia, diabetes and risk of fragility fractures: observational and Mendelian randomisation studies.","volume":"67","author":"Emanuelsson","year":"2024","journal-title":"Diabetologia"},{"key":"R4-20250812","doi-asserted-by":"crossref","first-page":"102130","DOI":"10.1016\/j.arr.2023.102130","article-title":"Dementia, osteoporosis and fragility fractures: intricate epidemiological relationships, plausible biological connections, and twisted clinical practices.","volume":"93","author":"Ruggiero","year":"2024","journal-title":"Ageing Res Rev"},{"key":"R5-20250812","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-024-00550-w","article-title":"Sarcopenia.","volume":"10","author":"Sayer","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"R6-20250812","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/biomedicines12040928","article-title":"Irisin and its role in postmenopausal osteoporosis and sarcopenia.","volume":"12","author":"Falsetti","year":"2024","journal-title":"Biomedicines"},{"key":"R7-20250812","doi-asserted-by":"crossref","first-page":"155638","DOI":"10.1016\/j.metabol.2023.155638","article-title":"Sarcopenia, osteoporosis and frailty.","volume":"145","author":"Gielen","year":"2023","journal-title":"Metab Clin Exp"},{"key":"R8-20250812","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician\u2019s guide to prevention and treatment of osteoporosis.","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int"},{"key":"R9-20250812","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00198-023-06863-y","article-title":"Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.","volume":"34","author":"Everts-Graber","year":"2023","journal-title":"Osteoporos Int"},{"key":"R10-20250812","first-page":"CD013451","article-title":"Bone-modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta-analysis.","volume":"7","author":"Adams","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-20250812","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00198-020-05498-7","article-title":"Upper gastrointestinal safety of oral bisphosphonate in hospitalized patients.","volume":"32","author":"Nguyen","year":"2021","journal-title":"Osteoporos Int"},{"key":"R12-20250812","doi-asserted-by":"crossref","first-page":"108168","DOI":"10.1016\/j.pharmthera.2022.108168","article-title":"Advances in pathogenesis and therapeutic strategies for osteoporosis.","volume":"237","author":"Song","year":"2022","journal-title":"Pharmacol Ther"},{"key":"R13-20250812","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00198-025-07440-1","article-title":"PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.","volume":"36","author":"Beaudart","year":"2025","journal-title":"Osteoporos Int"},{"key":"R14-20250812","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults.","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet"},{"key":"R15-20250812","doi-asserted-by":"crossref","first-page":"2295432","DOI":"10.1080\/19490976.2023.2295432","article-title":"Diets intervene osteoporosis via gut\u2013bone axis.","volume":"16","author":"Zhang","year":"2024","journal-title":"Gut Microbes"},{"key":"R16-20250812","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jot.2022.08.003","article-title":"Fecal microbiota transplantation ameliorates bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and metabolic function.","volume":"37","author":"Zhang","year":"2022","journal-title":"J Orthop Translat"},{"key":"R17-20250812","doi-asserted-by":"crossref","first-page":"102196","DOI":"10.1016\/j.arr.2024.102196","article-title":"Targeting the gut microbiota-related metabolites for osteoporosis: the inextricable connection of gut\u2013bone axis.","volume":"94","author":"Zhang","year":"2024","journal-title":"Ageing Res Rev"},{"key":"R18-20250812","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3350\/cmh.2019.0015","article-title":"Sarcopenia: ammonia metabolism and hepatic encephalopathy.","volume":"25","author":"Jindal","year":"2019","journal-title":"Clin Mol Hepatol"},{"key":"R19-20250812","doi-asserted-by":"crossref","first-page":"583478","DOI":"10.3389\/fphys.2020.583478","article-title":"Exercise-induced autophagy suppresses sarcopenia through Akt\/mTOR and Akt\/FoxO3a signal pathways and AMPK-mediated mitochondrial quality control.","volume":"11","author":"Zeng","year":"2020","journal-title":"Front Physiol"},{"key":"R20-20250812","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1039\/D2CS00957A","article-title":"Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates.","volume":"53","author":"Subbaiah","year":"2024","journal-title":"Chem Soc Rev"},{"key":"R21-20250812","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/ppul.25444","article-title":"Sildenafil for pulmonary hypertension in neonates: an updated systematic review and meta-analysis.","volume":"56","author":"He","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"R22-20250812","doi-asserted-by":"crossref","first-page":"e45142","DOI":"10.1371\/journal.pone.0045142","article-title":"The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors.","volume":"7","author":"Benisch","year":"2012","journal-title":"PLoS One"},{"key":"R23-20250812","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physiolgenomics.00249.2004","article-title":"Identification of a molecular signature of sarcopenia.","volume":"21","author":"Giresi","year":"2005","journal-title":"Physiol Genomics"},{"key":"R24-20250812","first-page":"e62528","article-title":"Three differential expression analysis methods for RNA sequencing: limma, EdgeR, DESeq2.","volume":"175","author":"Liu","year":"2021","journal-title":"J Vis Exp"},{"key":"R25-20250812","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2105-12-35","article-title":"VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R.","volume":"12","author":"Chen","year":"2011","journal-title":"BMC Bioinf"},{"key":"R26-20250812","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery.","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol"},{"key":"R27-20250812","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","article-title":"The reactome pathway knowledgebase 2024.","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"R28-20250812","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life.","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R29-20250812","doi-asserted-by":"crossref","first-page":"D1036","DOI":"10.1093\/nar\/gkv1165","article-title":"DGIdb 2.0: mining clinically relevant drug-gene interactions.","volume":"44","author":"Wagner","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R30-20250812","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data.","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"R31-20250812","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41467-021-20918-w","article-title":"Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women.","volume":"12","author":"Jones","year":"2021","journal-title":"Nat Commun"},{"key":"R32-20250812","doi-asserted-by":"crossref","first-page":"eabc8479","DOI":"10.1126\/science.abc8479","article-title":"Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span.","volume":"373","author":"Grunewald","year":"2021","journal-title":"Science"},{"key":"R33-20250812","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/biom14020176","article-title":"Mechanisms and functions of the RNA polymerase II general transcription machinery during the transcription cycle.","volume":"14","author":"Archuleta","year":"2024","journal-title":"Biomolecules"},{"key":"R34-20250812","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40265-023-01861-0","article-title":"Elacestrant: first approval.","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"key":"R35-20250812","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1200\/JCO.23.02112","article-title":"US Food and Drug Administration approval summary: elacestrant for estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated advanced or metastatic breast cancer.","volume":"42","author":"Shah","year":"2024","journal-title":"J Clin Oncol"},{"key":"R36-20250812","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00280-023-04550-7","article-title":"Pharmacology and pharmacokinetics of elacestrant.","volume":"92","author":"Beumer","year":"2023","journal-title":"Cancer Chemother Pharmacol"},{"key":"R37-20250812","doi-asserted-by":"crossref","first-page":"e2309591","DOI":"10.1002\/adma.202309591","article-title":"Synergistic chemoimmunotherapy augmentation via sequential nanocomposite hydrogel-mediated reprogramming of cancer-associated fibroblasts in osteosarcoma.","volume":"36","author":"Wang","year":"2024","journal-title":"Adv Mater"},{"key":"R38-20250812","doi-asserted-by":"crossref","first-page":"17285","DOI":"10.1021\/acsami.4c01451","article-title":"Proton sponge nanocomposites for synergistic tumor elimination via autophagy inhibition-promoted cell apoptosis and macrophage repolarization-enhanced immune response.","volume":"16","author":"Duan","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"R39-20250812","doi-asserted-by":"crossref","first-page":"e230116","DOI":"10.1530\/JOE-23-0116","article-title":"Postmenopausal osteoporosis coexisting with sarcopenia: the role and mechanisms of estrogen.","volume":"259","author":"Lu","year":"2023","journal-title":"J Endocrinol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:00:32Z","timestamp":1755018032000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":39,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042975","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}